Overview

A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this clinical trial was to compare the exposure and effect of NN1250 (insulin degludec) after different routes of injection in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin